Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Exponential Biotherapies Inc.

Latest From Exponential Biotherapies Inc.

Phico Therapeutics Ltd.

Phico is developing bacteriophage to deliver antibacterial-based drugs for treating antibiotic-resistant and other bacterial infections. But unlike others using bacteriophage themselves to attack bacteria, Phico's technology employs bacteriophage as the vehicle for delivering a protein that shuts down bacterial activity.
BioPharmaceutical Europe

Phage Therapeutics Inc.

Phage Therapeutics will combat bacterial infections with bacteriophage, a well-known class of viruses that infect bacteria and destroy them. PhageTx has been collecting genetically diverse bacteriophage specific for Staphylococcus aureus and S. epidermidis--the company's initial targets for therapy.

Effecting New Antibiotics, Part I

Gone are the days of random screening for new antibiotics. Now, thanks to molecular biology and genomics, start-up companies have a better sense of the mechanisms of infection. The firms think they've found novel ways to interfere with pathogens, including those resistant to current drugs.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Exponential Biotherapies Inc.
  • Senior Management
  • Contact Info
  • Exponential Biotherapies Inc.
    Rockville, MD